A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders.
暂无分享,去创建一个
D. Milea | D. Bonneau | P. Amati‐Bonneau | G. Lenaers | P. Reynier | V. Procaccio | S. Leruez | C. Verny | C. Bocca | J. Kouassi Nzoughet | M. Ferré | M. Kane | C. Veyrat-Durebex | J. M. Chao de la Barca | A. Chevrollier | C. Homedan | G. Simard | J. M. Chao De La Barca
[1] J. Grosgeorge,et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.
[2] S. Bhattacharya,et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.
[3] E. Zrenner,et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. , 2001, Human molecular genetics.
[4] B. Lorenz,et al. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy , 2003, Human mutation.
[5] Robert W. Taylor,et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. , 2008, Brain : a journal of neurology.
[6] R. Schwarzenbacher,et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. , 2008, Brain : a journal of neurology.
[7] D. Milea,et al. Hereditary optic neuropathies share a common mitochondrial coupling defect , 2008, Annals of neurology.
[8] F. Dekker,et al. Confounding: what it is and how to deal with it. , 2008, Kidney international.
[9] A. Martinuzzi,et al. Respiratory Complex I Dysfunction Due to Mitochondrial DNA Mutations Shifts the Voltage Threshold for Opening of the Permeability Transition Pore toward Resting Levels* , 2009, Journal of Biological Chemistry.
[10] Frans M van der Kloet,et al. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. , 2009, Journal of proteome research.
[11] D. Milea,et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations , 2009, Human mutation.
[12] D. Turnbull,et al. Multi-system neurological disease is common in patients with OPA1 mutations , 2010, Brain : a journal of neurology.
[13] J. Heymann,et al. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation , 2010, Human molecular genetics.
[14] R. Lewis,et al. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations. , 2011, Molecular genetics and metabolism.
[15] V. Desquiret-Dumas,et al. Standardized mitochondrial analysis gives new insights into mitochondrial dynamics and OPA1 function. , 2012, The international journal of biochemistry & cell biology.
[16] D. Milea,et al. Dominant optic atrophy , 2012, Orphanet Journal of Rare Diseases.
[17] H. Aburatani,et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.
[18] Marni J. Falk,et al. Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. , 2013, Molecular genetics and metabolism.
[19] M. Larsen,et al. Sensorineural hearing loss in OPA1-linked disorders. , 2013, Brain : a journal of neurology.
[20] C. La Morgia,et al. The optic nerve: A “mito-window” on mitochondrial neurodegeneration , 2013, Molecular and Cellular Neuroscience.
[21] V. Desquiret-Dumas,et al. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1. , 2014, Brain : a journal of neurology.
[22] M. Fasullo,et al. Nucleotide Salvage Deficiencies, DNA Damage and Neurodegeneration , 2015, International journal of molecular sciences.
[23] D. Milea,et al. Improved Locus‐Specific Database for OPA1 Mutations Allows Inclusion of Advanced Clinical Data , 2015, Human mutation.
[24] M. V. Heiden,et al. Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells , 2015, Cell.
[25] A. Dinkova-Kostova,et al. The emerging role of Nrf2 in mitochondrial function , 2015, Free radical biology & medicine.
[26] S. Tsang,et al. Phototransduction Influences Metabolic Flux and Nucleotide Metabolism in Mouse Retina* , 2015, The Journal of Biological Chemistry.
[27] Robert W. Taylor,et al. Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation , 2015, Journal of Medical Genetics.
[28] E. Thévenot,et al. Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses. , 2015, Journal of proteome research.
[29] Jianguo Xia,et al. Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis , 2016, Current protocols in bioinformatics.
[30] Philippe Rinaudo,et al. biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data , 2016, Front. Mol. Biosci..
[31] D. Milea,et al. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology , 2016, Neurobiology of Disease.
[32] P. Reynier,et al. Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis , 2016, Annals of clinical and translational neurology.
[33] D. Milea,et al. The metabolomic signature of Leber's hereditary optic neuropathy reveals endoplasmic reticulum stress. , 2016, Brain : a journal of neurology.
[34] P. Barboni,et al. A neurodegenerative perspective on mitochondrial optic neuropathies , 2016, Acta Neuropathologica.
[35] W. Craigen,et al. Mitochondrial DNA maintenance defects. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[36] D. Milea,et al. Targeted Metabolomics Reveals Early Dominant Optic Atrophy Signature in Optic Nerves of Opa1delTTAG/+ Mice. , 2017, Investigative ophthalmology & visual science.
[37] D. Bonneau,et al. A Nontargeted UHPLC-HRMS Metabolomics Pipeline for Metabolite Identification: Application to Cardiac Remote Ischemic Preconditioning. , 2017, Analytical chemistry.